Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Pathol Oncol Res ; 26(4): 2621-2632, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32632900

RESUMO

Due to the different mechanisms of cell-free DNA production, the single-stranded DNA to double-stranded DNA ratio in blood maybe different between healthy individuals and gastric cancer (GC) patients. We aimed to explore the potential application of this ratio in GC diagnosis. The plasma cell-free DNA extracts from 118 healthy individuals and 106 GC patients were prepared. The levels of single-stranded DNA or double-stranded DNA in plasma, and the single-stranded DNA to double-stranded DNA ratio on the diagnostic efficiency for GC were assessed with ROC curve. The relationships between this ratio and the clinical characteristics of GC patients were analyzed. The ratios in 63 GC patients before and after surgery were compared. In healthy individuals, the single-stranded DNA to double-stranded DNA ratio was not affected by factors including age, gender and BMI, and subjected to normal distribution (P = 0.1090). GC patients had a lower value of this ratio than healthy individuals (P < 0.0001). Considering this ratio as a GC diagnostic indicator, the area under ROC curve (AUC) was 0.923[95% confidence interval (CI):0.880-0.955]. This ratio in unresectable GC was obviously lower than that in resectable GC (P = 0.0045). There was a rank correlation between this ratio and GC TNM staging (rho = -0.266, P = 0.0058), but it had no correlation with tumor size (r = 0.14, P = 0.145). Additionally, this ratio was not affected by hemolysis and repeated freeze-thaw of blood samples, and was significantly elevated after surgery(P < 0.0001). The single-stranded DNA to double-stranded DNA ratio in plasma is a stable non-invasive indicator for GC diagnosis.


Assuntos
Biomarcadores Tumorais/genética , Ácidos Nucleicos Livres/genética , DNA de Cadeia Simples/genética , DNA/genética , Neoplasias Gástricas/diagnóstico , Adulto , Idoso , Ácidos Nucleicos Livres/sangue , DNA/sangue , DNA de Cadeia Simples/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Curva ROC , Neoplasias Gástricas/sangue , Neoplasias Gástricas/genética
2.
Int J Med Sci ; 8(1): 56-67, 2011 Jan 08.
Artigo em Inglês | MEDLINE | ID: mdl-21234270

RESUMO

To investigate the role of ROS in the helicobacter pylori (Hp) induced mtDNA mutations, AGS cells were treated by extracts of Hp11638 or Hp11638M. The ROS levels, cytochrome C reductions, and intracellular ATP levels were measured. The coding region and the D-Loop region were amplified and sequenced. Results showed the ROS levels, cytochrome C reduction and mtDNA mutations were markedly increased and cell viability decreased after treatment with both Hp extracts, and 616 mutations were detected in D-Loop region and 3 heteroplasmic point mutations in the Cytb gene. No mutations were found in the coding region. The mutation rates of mtDNA D-Loop region were positively correlated with the ROS levels and negatively to the ATP levels.


Assuntos
DNA Mitocondrial/genética , Helicobacter pylori/fisiologia , Mutação , Espécies Reativas de Oxigênio/metabolismo , Antígenos de Bactérias/análise , Antígenos de Bactérias/metabolismo , Proteínas de Bactérias/análise , Proteínas de Bactérias/metabolismo , Sequência de Bases , Extratos Celulares/química , Extratos Celulares/farmacologia , Linhagem Celular , Linhagem Celular Tumoral , Citocromos b/genética , Análise Mutacional de DNA , DNA Mitocondrial/efeitos dos fármacos , Helicobacter pylori/metabolismo , Humanos , Dados de Sequência Molecular , Mutação/efeitos dos fármacos , Mutação/fisiologia , Regulação para Cima/efeitos dos fármacos
3.
Zhonghua Yu Fang Yi Xue Za Zhi ; 45(12): 1099-102, 2011 Dec.
Artigo em Chinês | MEDLINE | ID: mdl-22336345

RESUMO

OBJECTIVE: To examine the prevalence changes of diabetes mellitus (DM) and impaired fasting glucose (IFG) from 2003 to 2010 in the health check-up subjects in Shanghai. METHODS: Health check-up subjects were divided into ten groups by sex and each 5 years old, and the prevalence of crude DM, crude IFG were calculated first. According to Chinese sex and age structure of China Population Statistics Yearbook 2006, sex and age standardized DM and standardized IFG were computed. RESULTS: In the same year, the prevalences of crude DM and IFG increased with increasing age for both male and female, reached the summit at 60 - 69 age group, when at ≥ 70 age group, they had a down trend and were still at higher level. The prevalences of crude DM were 3.99% (986/24 699) in male and 1.61% (176/10 948) in female in 2003, and were 7.85% (3366/42 899) and 2.55% (531/20 820) in 2010. The prevalences of crude IFG were 9.97% (2462/24 699) in male and 5.88% (644/10 948) in female in 2003, and were 30.96% (13 283/42 899) and 17.16% (3573/20 820) in 2010. The prevalences of age standardized DM in 2003 and 2010 were 3.89% and 6.90% for male (χ(2) = 371.89, P < 0.01), 2.12% and 3.23% for female (χ(2) = 29.32, P < 0.01), respectively. The prevalences of age standardized IFG in 2003 and 2010 were 9.51% and 28.55% (χ(2) = 3865.56, P < 0.01) for male, 6.97% and 17.88% (χ(2) = 790.81, P < 0.01) for female. The prevalences of age and sex standardized DM were 3.00% and 5.05% (χ(2) = 385.39, P < 0.01), and prevalences of age and sex standardized IFG were 8.23% and 23.17% (χ(2) = 4480.21, P < 0.01). CONCLUSION: From 2003 to 2010, prevalences of DM and IFG had increased greatly. It concluded that first-level prevention of DM for health check-up subjects should start from youth, and should lay emphasis on population of IFG, especially for male.


Assuntos
Glicemia/análise , Diabetes Mellitus/epidemiologia , Estado Pré-Diabético/epidemiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , China/epidemiologia , Jejum , Feminino , Teste de Tolerância a Glucose , Casas para Recuperação , Humanos , Masculino , Pessoa de Meia-Idade , Exame Físico , Prevalência
4.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi ; 27(4): 381-6, 2010 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-20677141

RESUMO

OBJECTIVE: To investigate the relationship between the helicobacter pylori (HP) infection and the genetic instability of mitochondrial DNA (mtDNA) in human gastric adenocarcinoma epithelial cells (AGS). METHODS: After treated with extracts of HP11638 (CagA+, VacA+) or Hp11638 mutant strain (CagA+, VacA-), AGS cells were collected, and mitochondrial DNA was extracted and Cox-I, Cox-II, Cox-III, ATPase6, ATPase8 and Cytb genes and the D-Loop region were amplified by PCR and then sequenced. RESULTS: The mutation rates of the mtDNA in AGS cells were correlated with the extracts of the two HP strains in a concentration- and time-dependent manner. But the mtDNA mutation rate in AGS cells treated with the HP11638 extract was higher than that treated with the Hp11638 mutant extract. Total of 616 mutations in D-Loop region were detected, including 489 point mutations, 81 insertions and 46 deletions. Among them, 70.9% (437/616) belonged to GC to AT and AT to GC transition. Seventeen out of 20 (85%) AGS cells treated with extract of HP had mutations in 303PolyC, 16184PolyC and 514CA regions of mtDNA D-Loop. No mutation was detected in Cox-I, Cox-II, Cox-III, ATPase6 and ATPase8 genes, three point mutations were found in the Cytb gene. CONCLUSION: HP can cause the accumulation of mutations in mtDNA, in particular, in the D-Loop region, and the VacA participated in the process.


Assuntos
DNA Mitocondrial/efeitos dos fármacos , Células Endoteliais/efeitos dos fármacos , Helicobacter pylori/química , Mutação , Estômago/patologia , Antígenos de Bactérias/farmacologia , Sequência de Bases , DNA Mitocondrial/genética , Células Endoteliais/patologia , Infecções por Helicobacter/complicações , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA